Related references
Note: Only part of the references are listed.Relatively Poor Survival of Mucinous Ovarian Carcinoma in Advanced Stage: A Systematic Review and Meta-analysis
Michiel Simons et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Quality of Life in Ovarian Cancer
Kassondra S. Grzankowski et al.
Cancer Control (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type
Michelle Moh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Ovarian carcinoma diagnosis: the clinical impact of 15 years of change
Stefan Kommoss et al.
BRITISH JOURNAL OF CANCER (2016)
An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience
Sandra Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
Martin Kobel et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
Katrina K. Au et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
Alicia A. Tone et al.
BMC CANCER (2014)
Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management
Jubilee Brown et al.
CURRENT ONCOLOGY REPORTS (2014)
Integrated analysis of germline and somatic variants in ovarian cancer
Krishna L. Kanchi et al.
NATURE COMMUNICATIONS (2014)
Specimen Quality Evaluation in Canadian Biobanks Participating in the COEUR Repository
Cecile Le Page et al.
BIOPRESERVATION AND BIOBANKING (2013)
Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium
Martin Kobel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
The Impact of Geographic Variations in Treatment on Outcomes in Ovarian Cancer
Ulrike Dehaeck et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study
Emine Karabuk et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2013)
Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
John R. McLaughlin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The Different Impact of BRCA Mutations on the Survival of Epithelial Ovarian Cancer Patients: A Retrospective Single-Center Experience
D. Lorusso et al.
ONCOLOGY (2013)
Advanced Cytoreductive Surgery Workshop Report
Krishnansu S. Tewari
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer Utility of a Histology-Based Referral Strategy
Kasmintan A. Schrader et al.
OBSTETRICS AND GYNECOLOGY (2012)
Improved Classification of Epithelial Ovarian Cancer Results of 3 Danish Cohorts
Karina Dahl Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
Gordon John Sampson Rustin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
M. P. Coleman et al.
LANCET (2011)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Morphological and molecular basis of ovarian serous carcinoma
Daniel G. Rosen et al.
JOURNAL OF BIOMEDICAL RESEARCH (2010)
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary
Muneaki Shimada et al.
GYNECOLOGIC ONCOLOGY (2009)
Molecular Origins of Cancer: Inherited Susceptibility to Common Cancers
William D. Foulkes
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families
Patricia N. Tonin et al.
FAMILIAL CANCER (2007)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer
WH Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2005)
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
J Boyd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
